$ARTL
Artelo Biosciences, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$2.50
▲After hours+4.13%+$0.099After hours
Artelo Biosciences, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is ARTL up today? It is at $2.50 (+15.16%), and our scanner flagged it 12 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ARTL spikes, and full due diligence on ARTL — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ARTL 12 times in the last 30 days. Create a free account to track $ARTL, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
ARTL is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on ARTL today, peaking at 2.8x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Likely catalystListing deficiency / delisting risk, from the latest SEC filing. Read it →Across every filing on file, supply equal to at least 72.5% of the tradeable float is in play - 72.5% more can still be issued.
Some filings did not state a size, so these are floors.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
At-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing)
387,282 new shares (adjusted for the later reverse split) · At-the-market (ATM) program — sells new shares into the market gradually over time · About $6.5M in size · Priced at $1.19/share
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
ARTL is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 1 unusual-volume and momentum alert on ARTL today, peaking at 2.8x its normal volume. A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
ARTL last traded at $2.50, up 15.16% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Artelo Biosciences, Inc. Common Stock (ARTL) is next expected to report earnings on Wednesday, November 11, 2026, about 8 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ARTL Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ARTL 12 times in the last 30 days.
ARTL (Artelo Biosciences, Inc. Common Stock) trades on XNAS, with a market cap of about $1M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ARTL for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ARTL discussion
Sign in to ask a question or join the discussion.